PET Staging Improves Survival in Small-Cell Lung Cancer
Using PET to stage patients with limited-stage small-cell lung cancer before treatment improves survival rate.
Patients with limited-stage small-cell lung cancer (LS-SCLC) who undergo pretreatment staging with PET showed better disease control and survival, according to a study published in the Journal of Thoracic Oncology.
In 2012, the National Comprehensive Cancer Network (NCCN) recommended that newly diagnosed patients with SCLC undergo a PET-CT, a change from their previous recommendation of a bone scan. Researchers from the University of Pennsylvania undertook a study to determine the clinical impact of the new recommendation.
Fifty-four patients with LS-SCLC who underwent concurrent chemoradiation from January 2001 to August 2010 were identified for the study. The researchers looked at the patients’ scanning history and treatment outcomes. All patients underwent thoracoabdominopelvic CT and MRI neuroimaging. Forty patients underwent PET.
The results showed that more patients who underwent PET staging presented with nodal metastases. The median overall survival from diagnosis in the patients who underwent PET before treatment was 32 months versus 17 months in patients staged without PET. Three-year survival was 47 percent (PET) versus 19 percent (non-PET).
“Pretreatment PET staging of LS-SCLC was associated with improved survival,” the authors wrote. “PET-staged patients had an improved three-year overall survival from diagnosis compared with those with LS-SCLC who were not staged with PET.”
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
